Pinealon is a synthetic tripeptide studied in vitro as a bioregulator, examined for its interaction with nucleic acids and gene-expression readouts in cell models. This profile describes the compound at the level of molecular biology.
What is pinealon?
Pinealon is a three-amino-acid synthetic peptide (Glu-Asp-Arg, EDR) used as a research material. It is described here only by structure and molecular role, as a laboratory compound. It belongs to the same Khavinson short-peptide family as the tetrapeptides Testagen (KEDG) and Livagen (KEDA), which share its Glu-Asp core, and the tripeptide Cartalax (Ala-Glu-Asp), which carries the same Glu-Asp pair with alanine rather than arginine as its third residue.
What it is studied for
In cell-based research, pinealon is studied for how it interacts with DNA and influences gene-expression readouts. The focus is mechanistic, examining molecular interactions in a defined system.
How it is studied in vitro
Researchers use cultured cells and gene-expression assays, such as measuring messenger RNA or reporter-gene activity, comparing conditions against proper controls.
Why a short peptide is studied this way
A small, well-defined peptide is a convenient tool for probing a specific molecular interaction in a reproducible laboratory system.
Related research guides
- Bioregulator compounds (overview)
- Epithalon (tetrapeptide)
- Khavinson short peptides: Testagen and Livagen
- Cartalax (AED tripeptide)
- Gene-expression assays
Research-use note
Pinealon is supplied as a research material for in vitro research use only. It is not for human or animal use.
Related research: Epithalon.
